Category: Analyst’s Comments
Analyst's Comments

CS Disco (LAW) Stock Jumped After-Hours On Friday, Why?

Shares of CS Disco Inc. (NYSE: LAW), the AI-powered legal technology giant, saw a significant boost of 4.26% in after-hours trading on Friday, reaching a trading price of $9.05, following the announcement of the anticipated release date of its financial results. What is the expected release date of LAW’s financials? As announced last week, CS Disco (LAW) will announce its financial results after market close on Thursday, February 23, 2023. CS Disco will host a conference call and webcast on the day of the earnings announcement. That will be to discuss the financial results and highlights of the business for
Analyst's Comments

Why Is Elys Game Technology Stock Increasing In Pre-Market Session Today?

Following the release of information on its annual general meeting, shares of Elys Game Technology Corp. (Nasdaq: ELYS) were up 26.50% at $0.3289 at the time of our last check in pre-market trading. When will ELYS convene its meeting? The annual meeting (the “Meeting”) of shareholders for Elys Game Technology (ELYS), is scheduled for Friday, December 30, 2022, at 8 a.m. (Eastern Standard Time) at the company’s Rome administrative offices at Villa Cavalletti, Via 24 Maggio, 73, 00046 Grottaferrata (Rome), received an update today. Elys Game Technology planned to take safeguards for social estrangement for individuals who attend the Meeting
Analyst's Comments

How Did The Outlook Therapeutics (OTLK) Stock Rise In The After-Hours Session?

After an application was approved, shares of Outlook Therapeutics Inc. (NASDAQ: OTLK) were up 12.70% to trade at $0.99 at the time of the most recent check. Which OTLK applications are verified? The European Medicines Agency (EMA) has approved ONS-5010 / LYTENAVA’s marketing authorization application, according to Outlook Therapeutics (OTLK) (bevacizumab-vikg). It is a wet age-related macular degeneration experimental ophthalmic dose of bevacizumab (wet AMD). The Committee for Medicinal Products for Human Use (CHMP) of the EMA is now prepared to formally assess the MAA, with an anticipated decision date of early 2024. Outlook Therapeutics is one step closer to
Analyst's Comments

Is This Why The SOBRsafe (SOBR) Stock Rose Pre-Hours Trading?

Following news of landing a significant customer, SOBRsafe Inc. (NASDAQ: SOBR) shares were up 18.79% to trade at $3.16 at the time of our last check. Tuesday’s session of SOBR ended at $2.66. Which client has SOBR secured? A well-known west coast commercial construction business has chosen SOBRcheck as the new front-line alcohol screening solution for its 400+ employees spread across numerous sites, according to a recent announcement from SOBRsafe (SOBR). The switch to SOBR’s cutting-edge safety technology by the construction industry, a longtime customer of SOBRsafe distributor Butterfield Onsite Drug Testing, supports the company’s sales strategy. Making Workplaces Safer
Analyst's Comments

What Was The Reason Behind Beam Global (BEEM) Stock Increasing In Extended Trades?

After obtaining a major order, Beam Global (NASDAQ: BEEM) is gaining on the charts, up 4.35% to trade at $10.80 at the most recent check after-hours. Shares of BEEM decreased -5.91% on Friday, closing the day at $10.35. Which order has BEEM secured? A nuclear waste management government contractor bought numerous EV ARC sustainable charging systems and an ARC Mobility trailer for effective system movement, according to a Beam Global (BEEM) announcement. The General Services Administration (GSA) Multiple Award Schedule (MAS) Contract Number 47QSWA21D0006 was used to acquire the systems, which streamlines the government procurement process and guarantees the best cost.
Analyst's Comments

What Caused The Kiromic (KRBP) Stock To Rise Today?

After receiving validation feedback, Kiromic BioPharma Inc. (Nasdaq: KRBP) stock gained 29.05% to $0.35 in current market conditions on the last check Thursday following its $0.27 closing price on Wednesday. How has KRBP been validated? In response to its Type B Pre-IND meeting request, Kiromic (KRBP) announced on October 4, 2022, that it received validating written feedback from the FDA regarding its Deltacel development strategy. Pre-IND meetings were requested to obtain FDA guidance on Kiromic’s proposed development strategy for Deltacel/KB-GDT for treating non-small cell lung cancer (NSCLC), including chemistry, manufacturing, and controls (CMC), nonclinical studies, and clinical study plans. For
Analyst's Comments

Why Did REE Automotive (REE) Stock Go Nearly 9% Higher After-Hours On Friday?

The share price of REE Automotive Ltd. (REE) increased 8.61% after-hours on Friday after the company announced the results of its share exchange offer. The stock fell by -29.24% to close at $0.75 at the end of the last trading session. How has REE described its offer results? A previously announced exchange offer (the “Offer”) by REE Automotive (REE) has expired, and its consent solicitation (the “Consent Solicitation”) has ended. In the offer, REE offered to purchase public warrants to buy Class A ordinary shares of the Company, with no par value (the “Class A ordinary shares”), which trade under
Analyst's Comments

How Has The Allakos (ALLK) Stock Appreciated Nearly 20% In The Recent Session?

On the last check Monday, Allakos Inc. (NASDAQ: ALLK) had gained 19.87% in the current market at $5.49 after announcing the pricing of its share offering. About 16.72 million shares have been traded so far today, up from 1.51 million shares on a daily average. ALLK has what to offer? Allakos (ALLK) announced today that it has priced 29,882,000 shares of its common stock in an underwritten offering. The price per share for the offering is $5.02. The offering includes shares by BVF Partners L.P., Deep Track Capital, Logos Capital, Frazier Life Sciences, Alta Partners, TCGX, New Enterprise Associates (NEA),
Analyst's Comments

Is There Anything Dragging The Tuesday Morning Corp (TUEM) Stock Premarket Today?

Tuesday Morning Corporation (TUEM) shares are down 19.04% at $0.2279 as of the last check, despite having entered into a debt financing agreement. The stock closed the last session at $0.28, down -7.61% or $0.02. What agreement has TUEM entered into? The Tuesday Morning Corp (TUEM) announced today that it has secured $32 million in convertible debt financing. The financing is has come through a special purpose vehicle (SPV) formed by the Retail Ecommerce Ventures LLC (“REV”). A further $3 million in convertible debt financing will be provided by members of TUEM’s management team, including Chief Executive Officer Fred Hand.
Analyst's Comments

Meta Platforms Inc. (META) Stock is A Good Trade Option?

Meta Platforms Inc. (NASDAQ: META) announced a year-on-year revenue drop for the first time since its inception as a public business. The announcement caused quotations to fall, despite Wall Street expecting a reduction in the company’s earnings. META was trading at $160.72 on July 28. Meta Platforms’ sales declined nearly 1% year on year to $28.82 billion in the second quarter, falling short of Wall Street’s expectations. Furthermore, the corporation claimed an insufficient rise in the number of new accounts. According to the most recent data, Meta Platforms has around 3.65 billion users. Meta Platforms has suffered a variety of

News IMC are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Quick Links

Categories

©2024, Fueled by Smart TechOne